Results 251 to 260 of about 88,244 (379)

Radiolabeling and biological characterization of TPGS-based nanomicelles by means of small animal imaging

, 2016
Fiorella Tesán, Mariano Gastón Portillo, Marcela A. Morettón, Ezequiel Bernabeu, Diego A. Chiappetta, María Jimena Salgueiro, Marcela Zubillaga   +6 more
openalex   +2 more sources

Burosumab in Unidentifiable Tumor‐Induced Osteomalacia

Clinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Tumor‐induced osteomalacia (TIO) can be challenging due to underlying tumors being either unresectable or unidentifiable. Burosumab, an anti‐FGF23 monoclonal antibody, has been proven to be effective in treating TIO but is currently not subsidized for this indication in Australia.
Yi Shan Der, Santosh Chaubey, Anna Mclean, Yasmin Trinh, Shelley Pember, Ashim Sinha   +5 more
wiley   +1 more source

A high-affinity CEA-targeted nanobody for ⁶⁸Ga PET imaging and ¹⁷⁷Lu-based radioisotope therapy: preclinical and first-in-human evaluation. [PDF]

J Nanobiotechnology
Zhang L, Zhou M, Lu C, Zhao P, Shi N, Zhou Y, Yao C, Yang X, Tian J, Wang J, Ma Y, Huang Q, Xu C, Gao P, Zhou W, Hu S, Luo L.   +16 more
europepmc   +1 more source

Pharmacokinetics, metabolism, excretion and safety of iruplinalkib (WX-0593), a novel ALK inhibitor, in healthy subjects: a phase I human radiolabeled mass balance study

Yicong Bian, Sheng Ma, Qingqing Yao, Tao Hu, Mingjing Ge, Hongting Li, Shansong Zheng, Zhe-ming Gu, Hao Feng, Zhenwen Yu, Chenrong Huang, Hua Zhang, Limei Zhao, Liyan Miao   +13 more
openalex   +1 more source

Enhancing Surgical Decision‐Making for Infected Cardiac Device Lead Removal With 18F‐FDG PET/CT: A Case Study and Literature Analysis

Clinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Residual implantable cardiac electronic device (ICED) leads pose a significant infection risk, necessitating a multimodal diagnostic and therapeutic approach. This case highlights the critical role of PET/CT imaging in guiding surgical decision‐making, particularly in cases of chronic infections with embedded or fractured lead fragments. While
Said Khallikane, Reda Mounir, Noureddine Atmani, Abdessamad Abdou, Ayoub Belhadj, Younes Aissaoui   +5 more
wiley   +1 more source

Evaluation of ¹⁶¹Tb-Labeled Diphosphonates as Potential Bone-Targeting Agents. [PDF]

Int J Mol Sci
Sitarica P, Vukadinović A, Marić M, Vranješ-Đurić S, Stanković D, Perić M, Janković D, Stanković D, Mirković M, Radović M.   +9 more
europepmc   +1 more source

Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications.

Accounts of Chemical Research, 2018
Dalong Ni, Dawei Jiang, Emily B. Ehlerding, Peng Huang, W. Cai   +4 more
semanticscholar   +1 more source

Ligandless Iron‐Catalyzed C(sp3)─H Bond Fluorination

ChemCatChem, Volume 18, Issue 1, 15 January 2026.
This study uses a simple transition metal complex, Fe(OTf)2 (OTf = CF3SO3−) as a catalyst for directing group‐free C(sp3)─H fluorination in the absence of any added ligand. This work includes condition optimization, substrate testing, and discusses a proposed catalytic cycle based on the results of control experiments.
A. Dina Dilinaer, Alexis Mateo, Marcus W. Drover   +2 more
wiley   +1 more source

MIB guides: [⁸⁹Zr]Zr-DFO-trastuzumab and [⁶⁴Cu]Cu-NOTA-Trastuzumab for Preclinical Cancer Imaging. [PDF]

Mol Imaging Biol
Simó C, Vanover AC, Azevedo EC, Pereira PMR.   +3 more
europepmc   +1 more source

Impact of Multiple S‐Palmitoylation on Peptide Ionization and Fragmentation in Mass Spectrometry

Chemistry–Methods, Volume 6, Issue 1, January 2026.
S‐palmitoylation is selectively introduced at potential modification sites of a model peptide. Modified peptides are then characterized by mass spectrometry, and the sites of modification are unambiguously identified. Lipidation, such as S‐palmitoylation, is an important, reversible post‐translational modification of proteins determining not only their
Elisa Badin, Carla Schmidt
wiley   +1 more source